Coral Laboratories quarterly results and financials

Coral Laboratories (BSE 524506)₹533.50+3.60%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Mar 2026 quarter (standalone), Coral Laboratories reported sales of ₹26.49 Cr, down 5.8% from Mar 2025, and net profit of ₹5.21 Cr, up 84.8% year on year. For the year to Mar 2026, sales were ₹86.01 Cr and net profit ₹15.98 Cr.

Sales (Mar 2026): ₹26.49 Cr
Net profit (Mar 2026): ₹5.21 Cr
Sales (FY Mar 2026): ₹86.01 Cr
Net profit (FY Mar 2026): ₹15.98 Cr
EPS (Mar 2026): ₹14.63
Borrowings (Mar 2026): ₹3.99 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Coral Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Coral Laboratories Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	13.54	23.14	18.07	28.88	31.65	32.22	22.97	28.11	18.81	19.02	21.57	26.49
Expenses	11.84	17.04	16.01	22.69	20.96	25.78	16.72	25.50	16.67	14.13	19.72	20.35
Operating Profit	1.73	6.14	2.09	6.24	10.73	6.50	6.31	2.68	2.17	4.93	1.88	6.19
OPM %	12.9%	26.6%	11.7%	21.7%	34.0%	20.2%	27.5%	9.6%	11.6%	26.0%	8.8%	23.4%
Other Income	1.30	1.82	1.38	2.01	1.57	2.55	2.53	1.72	2.06	3.04	2.50	2.65
Interest	0.00	0.00	0.00	0.00	0.04	0.02	0.03	0.05	0.07	0.11	0.00	0.02
Depreciation	0.54	0.43	0.48	0.49	0.48	0.50	0.49	0.50	0.44	0.44	0.68	0.53
Profit before tax	2.49	7.53	2.99	7.76	11.79	8.54	8.33	3.86	3.73	7.44	3.70	8.30
Tax %	26.1%	20.2%	27.5%	25.1%	25.1%	25.1%	26.0%	26.4%	31.1%	21.5%	24.9%	36.9%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−1.01	0.00	0.00	0.00	0.00
Net Profit	1.83	5.99	2.15	5.78	8.79	6.37	6.13	2.82	2.55	5.81	2.77	5.21
EPS (Rs)	5.16	16.80	6.06	16.22	24.67	17.87	17.21	7.93	7.18	16.31	7.79	14.63

Coral Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Coral Laboratories Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	76.99	95.01	91.98	90.92	71.02	96.94	76.01	77.98	83.96	115	86.01	85.89
Expenses	60.14	72.21	77.20	79.21	65.14	81.21	67.14	74.21	67.16	89.20	71.24	70.87
Operating Profit	15.99	22.99	15.01	12.01	4.99	15.98	7.99	3.99	15.99	25.99	14.99	15.17
OPM %	21.1%	24.0%	17.0%	14.0%	8.0%	16.0%	11.1%	4.9%	19.0%	23.1%	18.0%	17.7%
Other Income	3.01	3.01	4.01	5.01	6.01	4.01	6.01	7.02	6.01	8.01	10.03	10.25
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.20
Depreciation	1.99	1.99	1.99	1.99	1.99	1.99	1.99	1.99	1.99	1.99	1.99	2.09
Profit before tax	17.01	25.04	18.04	16.02	9.01	18.04	12.01	8.01	21.04	32.06	23.03	23.17
Tax %	29.0%	33.9%	30.9%	34.0%	22.0%	23.0%	23.9%	21.9%	23.9%	25.9%	28.9%	—
Exceptional items	0.00	−0.26	0.00	0.00	0.00	0.02	0.74	0.04	−0.13	−0.58	0.23	0.00
Net Profit	11.98	15.98	11.98	9.98	6.99	13.98	8.98	5.99	15.96	23.97	15.98	16.34
EPS (Rs)	34.74	45.71	34.86	28.65	19.99	37.95	25.36	18.08	44.22	67.67	45.90	45.91
Dividend payout %	9.0%	10.9%	6.0%	7.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	4.0%	—

Coral Laboratories balance sheet

₹ crore, at each year end.

Coral Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3.99	3.99	3.99	3.99	3.99	3.99	3.99	3.99	3.99	3.99	3.99	3.99
Reserves	55.90	66.86	106	113	110	112	133	152	151	174	198	205
Borrowings	0.99	0.00	1.99	2.01	0.99	5.99	5.99	5.99	0.00	0.00	3.99	3.99
Other Liabilities	12.03	18.98	20.07	22.08	21.11	23.01	25.09	27.98	20.05	27.98	25.12	27.13
Total Liabilities	71.91	88.83	131	140	136	144	168	190	174	206	229	241
Fixed Assets	19.06	18.07	18.06	22.10	23.11	23.09	21.09	24.09	25.08	24.10	23.09	44.17
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.99	0.00	0.00	1.99	0.00
Investments	0.99	4.99	38.92	44.94	27.96	24.97	32.97	45.93	40.98	49.93	51.93	45.95
Other Assets	51.86	66.77	73.80	72.81	83.79	96.67	112	118	108	132	152	149
Inventories	10.02	13.03	21.04	18.01	16.02	19.02	22.03	18.02	12.01	15.03	10.01	21.03
Trade receivables	25.10	28.12	31.13	32.14	30.14	34.12	39.17	38.14	23.11	28.12	34.15	29.11
Cash & equivalents	6.99	8.99	11.99	10.99	22.97	29.96	34.95	36.95	39.97	61.01	79.88	72.99
Total Assets	71.91	88.83	131	140	136	144	168	190	174	206	229	241

Coral Laboratories cash flow

₹ crore, for each year.

Coral Laboratories Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.00	4.99	11.01	13.01	−0.99	−4.01	0.99	6.01	12.99	−4.99	−1.01	16.01
Cash from investing activity	0.00	−3.01	−10.01	−13.02	3.01	−2.01	0.00	−6.01	−3.01	1.01	0.00	−18.03
Cash from financing activity	0.00	0.00	0.00	−2.99	−0.99	3.99	0.00	0.00	−5.99	0.00	2.99	0.00
Net cash flow	0.00	2.01	1.01	−2.01	1.01	−2.01	1.01	0.00	4.02	−4.01	1.01	−2.01
Capex	1.74	0.88	2.00	4.72	2.81	1.37	1.35	5.54	1.94	0.98	0.45	23.47
Free cash flow	−1.01	4.01	9.01	9.02	−4.01	−5.01	0.00	1.01	11.03	−6.01	−4.01	−5.01
CFO / OP %	30.0%	70.0%	85.0%	124.0%	31.0%	−59.0%	28.0%	127.0%	383.0%	−4.0%	23.0%	150.0%

Coral Laboratories ratios

Working-capital days and returns, by year.

Coral Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	153	133	118	126	123	179	149	185	110	124	108	126
Inventory days	110	110	155	120	116	176	158	169	100	149	68	211
Days payable	66	80	75	87	91	129	108	81	34	130	46	103
Cash conversion cycle	197	163	198	158	147	226	199	273	177	143	130	234
Working capital days	194	179	164	161	171	241	178	222	221	183	140	328
ROCE %	22.1%	27.1%	28.1%	16.1%	13.1%	8.0%	13.1%	7.0%	5.0%	13.1%	17.1%	11.1%

Coral Laboratories: frequently asked questions

What are the latest quarterly results of Coral Laboratories?

For the Mar 2026 quarter, Coral Laboratories reported sales of ₹26.49 Cr, down 5.8% year on year and net profit of ₹5.21 Cr, up 84.8% year on year. The operating margin was 23.4%.

What is the annual revenue of Coral Laboratories?

Coral Laboratories' sales for the year to Mar 2026 were ₹86.01 Cr; over the last twelve months they were ₹85.89 Cr.

What is the net profit of Coral Laboratories?

Net profit for the year to Mar 2026 was ₹15.98 Cr, and ₹16.34 Cr over the last twelve months. Earnings per share over the same trailing period were ₹45.91.

How much debt does Coral Laboratories have?

Coral Laboratories reported borrowings of ₹3.99 Cr at Mar 2026, against cash and equivalents of ₹72.99 Cr.

What is the free cash flow of Coral Laboratories?

Cash from operations was ₹16.01 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹5.01 Cr.

Loading…